Illumina to Offer $800M in Convertible Senior Notes

Net proceeds from the offering will be used to buy back common stock, fund conversion on currently outstanding convertible notes, and general corporate purposes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.